Dr. Patrick Tenbrink, MD

Dr. Tenbrink practices at Urology Group of Florida in Delray Beach, Florida.

Dr. Tenbrink's NPI, 1245685908, was assigned on May 2, 2016. Dr. Tenbrink graduated from University of Toledo College of Medicine and Life Sciences in 2016. Dr. Tenbrink holds Florida license ME149362.

Dr. Tenbrink's primary practice is Urology Group of Florida, at 5350 W Atlantic Ave, Delray Beach, FL 33484 in Palm Beach County. The practice phone is (561) 496-4444.

Dr. Tenbrink's primary practice is Urology Group of Florida in Delray Beach, Florida. Dr. Tenbrink is also affiliated with Cleveland Clinic Martin North Hospital. The medical group on file is Urology Group of Florida. Dmand AI also links Dr. Tenbrink to 1 more hospital, 3 group practices and clinics, 3 medical groups and 2 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tenbrink practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Tenbrink's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Tenbrink is board certified in urology by the American Board of Urology. Dr. Tenbrink is licensed in Florida.

CMS data shows 6,780 Medicare services from Dr. Tenbrink across 32 procedure codes in 2024, for 927 Medicare patients. Medicare paid $303,252 for them.

CMS counts 927 Medicare patients who saw Dr. Tenbrink in 2024. The largest group is 65 to 74, with 374 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tenbrink's median patient age at 73, with 27% women.

In 2024, Dr. Tenbrink wrote 1,340 Medicare Part D claims for 487 patients. 85% of them were for generic drugs. CMS names the drug for 1,268 of them, across 21 drugs with 11 or more claims each, at $138,298 in total drug cost. In 2023, CMS named 725 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Tenbrink for performance year 2024, reported individually. Dr. Tenbrink accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tenbrink as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Tenbrink, published from 2016 to 2018. Dr. Tenbrink's most frequent co-authors are Samer Othman Alharthi, MD, Samay Jain, MD and Khaled M. Shahrour, MD.

CMS Open Payments shows 178 general payments to Dr. Tenbrink from 32 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 72% of the total. PROCEPT BioRobotics Corporation paid the most, $1,828.

Dr. Tenbrink graduated from University of Toledo College of Medicine and Life Sciences in 2016.

Dr. Tenbrink is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.